Navigation Links
Optimum Timing for HIV/AIDS Prognosis

A new study shows the best time to make a prognosis for someone with HIV is six months after treatment begins. Researchers find cell counts //at that time give a more accurate picture of a person’s prognosis than when they are originally diagnosed with HIV.

Highly active antiretroviral therapy (HAART) is a common treatment for HIV patients. HAART has improved the prognosis of HIV patients, however there is not a lot of information on how to predict the prognosis of each patient. Researchers in Switzerland conducted a study looking at HIV patients who had received HAART. The study analyzed the patients’ cell counts and followed how well they fared.

Results showed patients with higher CD4 counts had lower risks of AIDS or death six months after starting HAART than patients with low CD4 counts. They also found lower viral load indicated a better prognosis. However, study authors say the measurements of the CD4 cells and the viral load at the beginning of therapy was not indicative of prognosis.

Study author Matthias Egger from the University of Bern says, "At six months after starting HAART, the current CD4 cell count and viral load, but not the values before the start of therapy, are strongly associated with subsequent disease progression. Our findings should inform guidelines on when to modify HAART in this group of patients who had not previously received antiretroviral therapy."
'"/>




Page: 1

Related medicine news :

1. Salad Contains Nutrients In Optimum Level
2. Optimum Period is Five Years to Treat Osteoporosis: Study
3. Optimum Folate and Vitamin B12 Levels Essential for Cognitive Function in Seniors
4. Timing Of Womens Labor May Determine Effectiveness Of Pain Medication
5. Drink till you drop dead in English Pubs- Restriction on Timings Lifted
6. Minimally Invasive Lung Cancer Surgery Minimize the Treatment Timings
7. Timing of Food Consumption Activates Genes in Specific Brain Area
8. Study on Timing of Spinal Surgery
9. Breast Cancer Risk Influenced by the Timing of Weight Gain
10. Timing of First Intercourse is Vital
11. Timing – Crucial for Asthma Drugs to Wor
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 2016 , ... This campaign aims to provide a path to improved education ... control and change. , As nearly 795,000 Americans suffering from a new or recurrent ... Plus, with an estimated 129,000 of these people dying from stroke, it’s become our ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... stories, courtesy of leaders in the nursing and health care industry. It also ... advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports ... Yellen and company to wait until March 2017 for an interest rate increase, according ... Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts are ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... Florida (PRWEB) , ... May 26, 2016 , ... ... House® Project offering a new model of care for living and healing, celebrated ... core values: Meaningful Life in a Real Home provided by Empowered Staff. , “This ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... NASHVILLE, Tenn. , May 26, 2016 ... provider of software and analytics, network solutions ... healthcare, today announced it entered into a ... leading provider of outpatient software solutions and ... surgery centers, specialty hospitals and rehabilitation clinics ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: